BR9307719A - Atovaquona na forma de partìculas, partìculas microfluidizadas de atovaquona, composição farmacêutica, e métodos para a preparação de partìculas microfluidizadas de atovaquona e para a preparaçào de composições farmacêuticas - Google Patents

Atovaquona na forma de partìculas, partìculas microfluidizadas de atovaquona, composição farmacêutica, e métodos para a preparação de partìculas microfluidizadas de atovaquona e para a preparaçào de composições farmacêuticas

Info

Publication number
BR9307719A
BR9307719A BR9307719-0A BR9307719A BR9307719A BR 9307719 A BR9307719 A BR 9307719A BR 9307719 A BR9307719 A BR 9307719A BR 9307719 A BR9307719 A BR 9307719A
Authority
BR
Brazil
Prior art keywords
particles
atovaquone
preparation
pharmaceutical composition
microfluidized
Prior art date
Application number
BR9307719-0A
Other languages
English (en)
Inventor
Alan Roy Dearn
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BR9307719A publication Critical patent/BR9307719A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fertilizers (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

Patente de Invenção "ATOVAQUONA NA FORMA DE PARTìCULAS, PARTìCULAS MICROFLUIDIZADAS DE ATOVAQUONA, COMPOSIçãO FARMACêUTICA, E MéTODOS PARA A PREPARAçãO DE PARTìCULAS MICROFLUDIZADAS DE ATOVAQUONA E PARA A PREPARAçãO DE COMPOSIçõES FARMACêUTICAS". A invenção refere-se a partículas microfluidisadas de atovaquona e a um método para prepará-las. Mais particularmente, a invenção diz respeito a uma composição farmacêutica contendo partículas microfuidisadas de atovaquona que tem biodisponibilidade melhorada e seu uso em terapia.
BR9307719-0A 1992-12-24 1993-12-23 Atovaquona na forma de partìculas, partìculas microfluidizadas de atovaquona, composição farmacêutica, e métodos para a preparação de partìculas microfluidizadas de atovaquona e para a preparaçào de composições farmacêuticas BR9307719A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226905A GB9226905D0 (en) 1992-12-24 1992-12-24 Pharmaceutical preparation
PCT/GB1993/002646 WO1994014426A1 (en) 1992-12-24 1993-12-23 Atovaquone pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BR9307719A true BR9307719A (pt) 1999-08-31

Family

ID=10727175

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9307719-0A BR9307719A (pt) 1992-12-24 1993-12-23 Atovaquona na forma de partìculas, partìculas microfluidizadas de atovaquona, composição farmacêutica, e métodos para a preparação de partìculas microfluidizadas de atovaquona e para a preparaçào de composições farmacêuticas

Country Status (36)

Country Link
US (2) US6018080A (pt)
EP (1) EP0675711B1 (pt)
JP (1) JP3461353B2 (pt)
KR (1) KR0175193B1 (pt)
CN (1) CN1076194C (pt)
AT (1) ATE169215T1 (pt)
AU (2) AU675102B2 (pt)
BG (1) BG61932B1 (pt)
BR (1) BR9307719A (pt)
CA (1) CA2152615C (pt)
CZ (1) CZ289701B6 (pt)
DE (1) DE69320208T2 (pt)
DK (1) DK0675711T3 (pt)
ES (1) ES2122223T3 (pt)
FI (1) FI114007B (pt)
GB (1) GB9226905D0 (pt)
GE (1) GEP19991515B (pt)
HK (1) HK1004086A1 (pt)
HR (1) HRP931516B1 (pt)
HU (1) HU220215B (pt)
IL (1) IL108154A (pt)
MY (1) MY109990A (pt)
NO (1) NO316745B1 (pt)
NZ (1) NZ258995A (pt)
PL (1) PL175374B1 (pt)
RO (1) RO119686B1 (pt)
RU (1) RU2127585C1 (pt)
SA (1) SA94140644B1 (pt)
SG (1) SG43901A1 (pt)
SI (1) SI9300678A (pt)
SK (1) SK281924B6 (pt)
TW (2) TW443935B (pt)
UA (1) UA39879C2 (pt)
WO (1) WO1994014426A1 (pt)
YU (1) YU48919B (pt)
ZA (1) ZA939673B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
AU3705695A (en) * 1994-10-26 1996-05-23 Wellcome Foundation Limited, The Pharmaceutical composition comprising atovaquone
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
GB9424013D0 (en) * 1994-11-29 1995-01-18 Wellcome Found Medicaments
CA2321924A1 (en) 1998-02-25 1999-09-02 Abbott Laboratories Butorphanol sustained release formulations
US6503949B1 (en) 1999-05-17 2003-01-07 Noro Nordisk A/S Glucagon antagonists/inverse agonists
US6562807B2 (en) 2000-06-23 2003-05-13 Novo Nordisk A/S Glucagon antagonists/inverse agonists
US6821960B2 (en) 2000-11-17 2004-11-23 Noyo Nordisk Pharmaceuticals, Inc. Glucagon antagonists/inverse agonists
US6706744B2 (en) 2000-11-17 2004-03-16 Novo Nordisk A/S Glucagon antagonists/inverse agonists
AU2002223500A1 (en) 2000-11-17 2002-05-27 Novo-Nordisk A/S Glucagon antagonists/inverse agonists
US6881746B2 (en) 2001-12-03 2005-04-19 Novo Nordick A/S Glucagon antagonists/inverse agonists
US6762318B2 (en) 2001-12-03 2004-07-13 Novo Nordisk A/S Glucagon antagonists
US7183518B2 (en) * 2004-09-24 2007-02-27 Michael Near System of food storage preparation and delivery in finished cooked state
DE102005011786A1 (de) * 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
ES2338039T3 (es) * 2005-04-13 2010-05-03 ABBOTT GMBH & CO. KG Procedimiento para la obtencion cuidadosa de supensiones de particulas de elevada finura y particulas de elevada finura, asi como su aplicacion.
US20080241254A1 (en) * 2007-01-02 2008-10-02 Suryakant Navale Pharmaceutical composition comprising atovaquone particles
DE102007001473A1 (de) 2007-01-08 2008-07-10 Andreas Lemke Verfahren zur Herstellung und Anwendung von Mikro- und/oder Nanosuspensionen durch aufbauende Mikronisierung in Gegenwart von Trockeneis und hohem Druck
WO2009007991A2 (en) * 2007-04-19 2009-01-15 Ipca Laboratories Limited A new process for preparation of atovaquone and novel intermediates thereof
EP2318350A4 (en) * 2008-07-25 2012-11-28 Alphapharm Pty Ltd ATOVAQUONE WITH PARTICLE DIAMETER (D90) VARIANT FROM MORE THAN 3 muM TO ABOUT 10 muM
US20100099776A1 (en) * 2008-10-20 2010-04-22 Ranbaxy Laboratories Limited Oily suspension of atovaquone
ES2517366T3 (es) 2009-08-20 2014-11-03 Ipca Laboratories Limited Nuevo complejo para el tratamiento y/o profilaxis de infecciones parasitarias
CA2780292A1 (en) 2009-11-10 2011-05-19 Celgene Corporation Nanosus pens ion of a poorly soluble drug made by microfluidization process
WO2011151418A2 (en) 2010-06-02 2011-12-08 Abbott Gmbh & Co. Kg Nanosusupension formulation comprising a polydimethylsiloxane hydrophobic phase
EP2934484A1 (en) 2012-12-19 2015-10-28 Kashiv Pharma, LLC Supersaturated stabilized nanoparticles for poorly soluble drugs
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
WO2017216564A1 (en) * 2016-06-16 2017-12-21 The University Of Liverpool Chemical composition
US20220265566A1 (en) * 2018-10-18 2022-08-25 Tulex Pharmaceuticals Inc. Atovaquone nanoparticulate compositions

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533648A (en) * 1949-03-05 1950-12-12 Joseph H Warburg Circular saw making
NL6411993A (pt) * 1963-10-18 1965-04-20
US3347830A (en) * 1964-07-30 1967-10-17 Grace W R & Co Process of polymerizing formaldehyde
GB1141735A (en) * 1966-11-23 1969-01-29 Pfizer & Co C Pharmaceutical anti-tumor composition
US3655699A (en) * 1970-03-02 1972-04-11 Pfizer Analogues of lapachol as antitumor agents
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE2601458A1 (de) * 1975-01-20 1976-07-22 Ciba Geigy Ag Loesliche, von phenylindandiaminen abgeleitete polyamide
JPS5492945A (en) * 1977-11-22 1979-07-23 Wellcome Found Naphthoquinone derivative
US4485117A (en) 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
DE3141691A1 (de) * 1981-10-21 1983-05-19 Hoechst Ag, 6230 Frankfurt Plasmid pac 1, verfahren zu seiner gewinnung und seine verwendung
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
US5175319A (en) 1983-04-14 1992-12-29 Burroughs Wellcome Co. Naphthoquinone derivatives
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
IL85097A (en) * 1987-01-30 1992-02-16 Exxon Chemical Patents Inc Catalysts based on derivatives of a bis(cyclopentadienyl)group ivb metal compound,their preparation and their use in polymerization processes
PL276385A1 (en) * 1987-01-30 1989-07-24 Exxon Chemical Patents Inc Method for polymerization of olefines,diolefins and acetylene unsaturated compounds
US4783389A (en) * 1987-03-27 1988-11-08 E. I. Du Pont De Nemours And Company Process for preparation of liquid electrostatic developers
US5155080A (en) * 1988-07-15 1992-10-13 Fina Technology, Inc. Process and catalyst for producing syndiotactic polyolefins
US5225500A (en) * 1988-07-15 1993-07-06 Fina Technology, Inc. Process and catalyst for producing syndiotactic polyolefins
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
JP2804302B2 (ja) * 1988-08-16 1998-09-24 ザ ウエルカム フアウンデーション リミテッド 治療剤
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
KR930002411B1 (ko) * 1988-09-14 1993-03-30 미쓰이세끼유 가가꾸고오교오 가부시끼가이샤 벤젠불용성 유기알루미늄 옥시화합물 및 그 제조방법
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
EP0427697B1 (en) * 1989-10-10 1996-05-08 Fina Technology, Inc. Metallocene catalysts with Lewis acids and aluminum alkyls
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
ES2086397T5 (es) * 1989-10-30 2005-07-16 Fina Technology, Inc. Adicion de alkiloaluminio para un catalizador metaloceno mejorado.
US5387568A (en) * 1989-10-30 1995-02-07 Fina Technology, Inc. Preparation of metallocene catalysts for polymerization of olefins
DE3942363A1 (de) * 1989-12-21 1991-06-27 Hoechst Ag Verfahren zur herstellung einer polypropylen-formmasse
JP2545006B2 (ja) * 1990-07-03 1996-10-16 ザ ダウ ケミカル カンパニー 付加重合触媒
JP3076619B2 (ja) 1991-05-14 2000-08-14 三井化学株式会社 ブロック共重合体の製造方法
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
US5766522A (en) * 1996-07-19 1998-06-16 Morton International, Inc. Continuous processing of powder coating compositions
US5976578A (en) * 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
US5914135A (en) * 1997-04-16 1999-06-22 Mcneil-Ppc, Inc. Liquid antacid compositions

Also Published As

Publication number Publication date
DE69320208D1 (de) 1998-09-10
SK82895A3 (en) 1995-11-08
AU675102B2 (en) 1997-01-23
WO1994014426A1 (en) 1994-07-07
HRP931516B1 (en) 1999-04-30
MY109990A (en) 1997-10-31
EP0675711A1 (en) 1995-10-11
SI9300678A (en) 1994-09-30
YU48919B (sh) 2002-11-15
JP3461353B2 (ja) 2003-10-27
TW443935B (en) 2001-07-01
NO316745B1 (no) 2004-04-26
GEP19991515B (en) 1999-03-05
JPH08504805A (ja) 1996-05-28
HUT71528A (en) 1995-12-28
CA2152615A1 (en) 1994-07-07
HU9501812D0 (en) 1995-08-28
CA2152615C (en) 2001-10-16
US6018080A (en) 2000-01-25
IL108154A0 (en) 1994-04-12
HU220215B (hu) 2001-11-28
RO119686B1 (ro) 2005-02-28
GB9226905D0 (en) 1993-02-17
NO952522L (no) 1995-06-22
AU1627997A (en) 1997-05-22
FI953139A0 (fi) 1995-06-22
SK281924B6 (sk) 2001-09-11
FI953139A (fi) 1995-06-22
CZ145195A3 (en) 1995-10-18
PL309629A1 (en) 1995-10-30
BG61932B1 (bg) 1998-10-30
EP0675711B1 (en) 1998-08-05
FI114007B (fi) 2004-07-30
DK0675711T3 (da) 1999-05-03
HK1004086A1 (en) 1998-11-13
DE69320208T2 (de) 1999-01-21
ES2122223T3 (es) 1998-12-16
AU696662B2 (en) 1998-09-17
CZ289701B6 (cs) 2002-03-13
UA39879C2 (uk) 2001-07-16
NZ258995A (en) 1997-01-29
NO952522D0 (no) 1995-06-22
RU2127585C1 (ru) 1999-03-20
ATE169215T1 (de) 1998-08-15
IL108154A (en) 2000-02-17
PL175374B1 (pl) 1998-12-31
ZA939673B (en) 1995-06-23
YU80893A (sh) 1997-03-07
CN1103290A (zh) 1995-06-07
AU5710594A (en) 1994-07-19
HRP931516A2 (en) 1995-10-31
TW514531B (en) 2002-12-21
BG99723A (bg) 1996-01-31
SA94140644B1 (ar) 2005-06-14
US6649659B1 (en) 2003-11-18
KR950703942A (ko) 1995-11-17
KR0175193B1 (ko) 1999-02-01
CN1076194C (zh) 2001-12-19
SG43901A1 (en) 1997-11-14

Similar Documents

Publication Publication Date Title
BR9307719A (pt) Atovaquona na forma de partìculas, partìculas microfluidizadas de atovaquona, composição farmacêutica, e métodos para a preparação de partìculas microfluidizadas de atovaquona e para a preparaçào de composições farmacêuticas
ES537578A0 (es) Procedimiento para la estabilizacion de preparados farmaceuticos en forma de suspensiones conteniendo sucralfato
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
BR9808812A (pt) Composição compreendendo partìculas cristalinas, finamente divididas de budesonida
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
UA29507C2 (uk) Фармацевтична композиція для інгаляції та спосіб її одержання
BR9811249A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
ES2031904T3 (es) Procedimiento para producir una composicion farmaceutica que contiene ibuprofeno y hidroxido de aluminio.
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
EP0232982A3 (en) Treatment of skin disorders
PT94247A (pt) Processo para a preparacao de uma composicao farmaceutica contendo 3'-azido-3'-desoxitimidina e n-butil-desoxinojirimicina e metodo para inibir hiv utilizando-a
IT1241997B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
DK524884D0 (da) Farmaceutiske praeparater indeholdende phosphatidylserin og fremgangsmaade til fremstilling deraf
CS545686A1 (en) Farmaceuticky prostredek a antihepatotoxickym pusobenim
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
BR9907025A (pt) Polissacarìdeos sintéticos, processo para sua preparação e composições farmacêuticas que contêm os mesmos
ATE99945T1 (de) Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.
AU4150489A (en) Micronised drug formulation
BR9801511A (pt) Uso de ácido hialurÈnico ou um de seus sais farmaceuticamente aceitáveis e solução aquosa contendo ácido hialurÈnico ou um de seus sais farmaceuticamente aceitáveis.
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
CA2150234C (en) COMBINATION OF ATOVAQUONE AND PROGUANIL FOR THE TREATMENT OF PROTOZOA INFECTION
ES2036174T3 (es) Un procedimiento para la preparacion de una combinacion broncodilatadora de prazosin-pirbuterol.
BR9915071A (pt) Utilização de uma proteìna ompa de enterobactéria ou de um de seus fragmentos
SE8403659D0 (sv) Synergistic pharmaceutical composition

Legal Events

Date Code Title Description
FC Decision: refusal